Press ESC to close

Peptide Lab App Log in Articles News Guide Products
More Peptide Tracker Calculator Best Calculators Peptide Statistics Contact Newsletter
Français English Deutsch Español Português العربية Polski 한국어 日本語 中文 Русский

Are peptides legal in Italy?

Last verified: Regulator: Agenzia Italiana del Farmaco (AIFA)

The short answer

In Italy the peptide active substances semaglutide and tirzepatide appear in AIFA Nota 100, which lists the medicines charged to the national health service for type 2 diabetes, with a first prescription form, a renewal form and computerised prescription through the TS system. AIFA states that the structure of the national legal supply chain, in production and distribution, makes the infiltration of falsified products almost impossible, and that such products spread only through illegal channels such as unauthorised websites and platforms. For peptides sold "for research use only" the sources consulted give no rule on sale, purchase or possession. This page is general information, not legal advice.

Status by category

CategoryStatus
Approved peptide medicinesRestricted
Research peptidesUnclear
Compounded preparationsRestricted
CosmeticsNot regulated as a medicine
Food supplementsUnclear
Personal importUnclear
Sport and anti-dopingProhibited

Approved peptide medicines Restricted

AIFA Nota 100 lists the medicines charged to the national health service for type 2 diabetes, including semaglutide among GLP-1 receptor agonists and tirzepatide as a GIP/GLP-1 dual agonist. Nota 100 has a first prescription form and a prescription renewal form, and computerised prescription through the TS system was activated for Nota 100 medicines and later for tirzepatide. The source consulted is a reimbursement note and does not state a supply classification. [1]

Research peptides Unclear

No specific official rule found.

Compounded preparations Restricted

Doctors and pharmacists may not prescribe or prepare weight loss magistral preparations containing the banned active substances, and a decree of 1 June 2021 forbids the preparation of galenic medicines containing substances classified as androgenic anabolic steroids. Pharmacists must also transmit the data on quantities of active substances prohibited for doping used in extemporaneous preparations, only from a certified PEC mailbox to the Ministry of Health mailbox [email protected], and files sent from non PEC mailboxes are not considered. The Ministry notice lists classes that are not subject to transmission, each only within the limits and routes of administration it sets, for example felypressin for local administration in dental anaesthesia, imidazoline derivatives for dermatological, nasal, ophthalmic or otic use, and glucocorticosteroids by other routes of administration when they are used in the authorised doses and therapeutic indications. [3][5][6]

Cosmetics Not regulated as a medicine

Cosmetic products placed on the market must comply with Regulation (EC) 1223/2009, and the Ministry of Health carries out market surveillance and cosmetovigilance. The sources consulted set out this general cosmetic framework and do not name peptides as such. [8]

Food supplements Unclear

No specific official rule found.

Personal import Unclear

No specific official rule found.

Sport and anti-doping Prohibited

The WADA Prohibited List is the International Standard that identifies substances and methods prohibited in sport; it is updated every year and enters into force on 1 January. The Ministry of Health states that the list published on the WADA site and in the decree of 3 June 2025 is an integral and substantial part of the 2025 doping substances, and that BPC-157 is now prohibited as S0. [3][4]

Peptide by peptide

PeptideStatusDetails
semaglutideRestrictedSemaglutide is listed in AIFA Nota 100 among the GLP-1 receptor agonists charged to the national health service, with a first prescription form and computerised prescription. [1]
tirzepatideRestrictedTirzepatide is listed in AIFA Nota 100 as a GIP/GLP-1 dual receptor agonist, with reimbursement granted in February 2025 and computerised prescription activated in April 2025. [1]
BPC-157ProhibitedBPC-157 is listed by the Ministry of Health among the substances now prohibited for doping in category S0, and the sources consulted give no rule on its sale, supply or possession. [3]

Change history

  1. AIFA reported that the Ministry of Health signed a decree banning weight loss magistral preparations containing triac, clorazepate, fluoxetine, furosemide, metformin, bupropion and topiramate, so doctors and pharmacists may neither prescribe nor prepare them. [5]
  2. Decree of 1 June 2021: ban on the preparation of galenic medicines containing substances classified as androgenic anabolic steroids. [6]
  3. Decree of 4 August 2021: revision of the list of medicines, biologically and pharmacologically active substances and medical practices whose use is considered doping. [6]
  4. AIFA determination of 21 January 2022, listed among the acts of Nota 100 on medicines for type 2 diabetes. [1]
  5. Computerised prescription of Nota 100 medicines by general practitioners through the TS system was activated. [1]
  6. Table B of AIFA Nota 100 was updated for medicines for the treatment of type 2 diabetes. [1]
  7. Reimbursability of the new active substance tirzepatide for the treatment of type 2 diabetes. [1]
  8. Computerised prescription through the TS system was activated for tirzepatide in Nota 100. [1]
  9. Decree of 3 June 2025, the latest revision of the list of substances prohibited for doping. [3]
  10. AIFA Nota 100 on medicines for the treatment of type 2 diabetes was updated. [1]
  11. AIFA published the EMA and HMA alert on the strong increase of illegal medicines sold in the EU as GLP-1 receptor agonists, such as semaglutide, liraglutide and tirzepatide. [2]
  12. Important safety communication (NIIS) on Rybelsus, oral semaglutide. [1]
  13. The annexes of Nota 100, the first prescription form and the prescription renewal form, were updated. [1]
  14. From 1 January 2026 pharmacists must send electronically, by 31 January 2026, the data on quantities of active substances prohibited for doping used in extemporaneous preparations during 2025; transmission must come only from a PEC mailbox to [email protected], files from non PEC mailboxes are not considered, and the classes listed in the Ministry notice are not subject to transmission within the limits and routes of administration set there. [3]

Official sources

  1. Nota 100 (semaglutide, tirzepatide e altri antidiabetici: condizioni di prescrizione e rimborsabilità SSN), AIFA - Agenzia Italiana del Farmaco
  2. Allerta sull'aumento di farmaci illegali venduti nell'UE come agonisti del recettore del GLP-1 (04/09/2025), AIFA - Agenzia Italiana del Farmaco
  3. Sostanze dopanti: trasmissione dei dati sui principi attivi vietati per doping (cita BPC-157 in classe S0, DM 3 giugno 2025 e lista WADA), Ministero della Salute
  4. Lista delle Sostanze e dei Metodi Proibiti WADA (edizione in vigore dal 1° gennaio 2026), NADO Italia - Organizzazione Nazionale Antidoping
  5. Ministero Salute emette divieto di prescrizione e allestimento di preparazioni magistrali a scopo dimagrante a seguito di segnalazioni AIFA, AIFA - Agenzia Italiana del Farmaco
  6. Normativa di riferimento - Farmaci (D.Lgs. 219/2006, importazione parallela, medicinali falsificati, legge 376/2000 sul doping), AIFA - Agenzia Italiana del Farmaco
  7. Integratori alimentari: documenti approvati e Linee guida ministeriali (incluse le "altre sostanze ad effetto nutritivo o fisiologico"), Ministero della Salute
  8. Sicurezza dei cosmetici (Regolamento CE 1223/2009, persona responsabile, notifica CPNP, cosmetovigilanza), Ministero della Salute

General information, not legal advice. Rules change: check the official source before you act.